AllerGen launches first globally-accessible allergy and asthma molecular network database
AllerGen’s Allergy and Asthma Portal (AAP)—a unique, web-accessible database that houses over 900 biomolecular interactions relevant to allergy and asthma—is now open to the public.
The AAP is the first resource of its kind and is available for use by allergy and asthma researchers worldwide. It represents the most comprehensive database of the genes, proteins, biomolecular interactions and pathways associated with immunity and allergic diseases, and will aid in the development of new therapies for allergies and asthma.